Published in Medical Letter on the CDC and FDA, June 13th, 2004
According to recent research from the Netherlands, "Two considerations led us to study the genetic diversity and origin of hepatitis B virus (HBV) in Dutch blood donors. First, an HBV-infected Dutch blood donor was found negative by four assays used commonly for detection of HBV surface antigen (HBsAg). How variable is HBsAg among HBV infected blood donors' Second, the World Health Organization (WHO) recommends universal vaccination against HBV, but northwest European countries limit vaccination to groups at risk of HBV. This...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA